As of November 2024, Shenzhen Hepalink Pharmaceutical Group has a market cap of $1.64B. This makes Shenzhen Hepalink Pharmaceutical Group the world's 5846th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.54B | -25.40% |
2023 | $2.07B | -8.72% |
2022 | $2.26B | -24.85% |
2021 | $3.01B | -0.70% |
2020 | $3.03B | -11.74% |
2019 | $3.44B | -15.36% |
2018 | $4.06B | 50.85% |
2017 | $2.69B | -16.14% |
2016 | $3.21B | -17.58% |
2015 | $3.89B | 37.09% |
2014 | $2.84B | 27.09% |
2013 | $2.23B | 8.27% |
2012 | $2.06B | -24.09% |
2011 | $2.72B | -64.49% |
2010 | $7.66B | - |